← Back to Patent Explorer
US4897412A Expired / Lapsed US ⏱️ 0.0 years remaining

Imidazolines useful in lowering intraocular pressure

Assignee: Laboratoires Alcon SAS
•
Filing: 1989-01-19
•
Granted: 1990-01-30
•
Expires: 2009-01-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Antiglaucoma compounds having beta adrenoreceptor antagonist properties and alpha adrenoreceptor antagonist properties are described. The compounds comprise a beta blocker-derived moiety designed to provide beta antagonist properties and an imidazolidine moiety designed to provide alpha-antagonist properties. Methods of synthesizing the compounds are also described. The compounds are useful in the treatment of glaucoma due to their ability to lower elevated intraocular pressure.

Inventors

  • 👤 Gerard LeClerc
  • 👤 Didier Huber
  • 👤 Jacques Himber
  • 👤 Guy Andermann

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 17:27
CPC Classifications
C; C07; C07D; C07D233/00; C07D233/04; C07D233/20; C07D233/22; C07D233/28; C07D233/44; C07D233/50

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 8 words
A compound formula: ##STR9## wherein R is ##STR10##
Claim 2
Dependent Claim 8 words
A compound formula: ##STR9## wherein R is ##STR10##
Claim 3
Dependent Claim 32 words
A topical ophthalmic composition useful in the treatment of elevated intraoccular pressure, comprising an effective amount of a compound of formula: ##STR11## wherein R is ##STR12## and a pharmaceutically acceptable carrier therefor.
Claim 4
Dependent Claim 32 words
A topical ophthalmic composition useful in the treatment of elevated intraoccular pressure, comprising an effective amount of a compound of formula: ##STR11## wherein R is ##STR12## and a pharmaceutically acceptable carrier therefor.
Claim 5
Dependent Claim 21 words
A method of lowering intraocular pressure which comprises applying an ophthalmic composition according to claim 2 topically to the affected eye.

References Cited (Backward Citations)

US4195085A Cited
US4342783A Cited
US4450170A Cited
US4461904A Cited
US4515800A Cited
US4517199A Cited
US4444782A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-01-29 1993-07-31 1994-01-30 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-01-29 1997-07-31 1998-01-30 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-01-29 2001-07-31 2002-01-30 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag